Your session is about to expire
← Back to Search
Cognitive-Behavioral Therapy
Communication & Coping Intervention for Type 1 Diabetes (T1D Trial)
N/A
Waitlist Available
Led By Sarah Jaser, PhD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
T1D Trial Summary
This trial will evaluate a cognitive-behavioral intervention for mothers of adolescents with type 1 diabetes to promote the use of adaptive coping strategies and positive parenting practices, in order to improve outcomes for the adolescents.
Eligible Conditions
- Type 1 Diabetes
T1D Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Glycemic control (A1C)
Secondary outcome measures
Adolescent Adherence
Adolescent Diabetes Distress
Adolescent psychosocial functioning - parent report
+12 moreT1D Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Communication & Coping InterventionExperimental Treatment1 Intervention
A cognitive behavioral intervention for mothers of adolescents with type 1 diabetes to improve coping and the quality of parental involvement.
Group II: Education & Check InsActive Control1 Intervention
The comparison group receives educational materials on diabetes management and phone calls, as well as access to a secret Facebook group with daily posts on diabetes management.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Communication & Coping Intervention
2019
N/A
~160
Find a Location
Who is running the clinical trial?
Vanderbilt University Medical CenterLead Sponsor
857 Previous Clinical Trials
672,039 Total Patients Enrolled
University of ConnecticutOTHER
184 Previous Clinical Trials
158,139 Total Patients Enrolled
Sarah Jaser, PhDPrincipal Investigator - Vanderbilt University Medical Center
Vanderbilt University Medical Center
1 Previous Clinical Trials
48 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are a teenager who has had type 1 diabetes for at least one year.The person taking care of you has a history of severe mental health problems like bipolar disorder or schizophrenia.The person taking care of you has severe signs of sadness and hopelessness.The caregiver shows symptoms of mild to moderate depression or diabetes-related distress.The caregiver reports that you have a history of severe mental health issues such as bipolar disorder or schizophrenia.
Research Study Groups:
This trial has the following groups:- Group 1: Education & Check Ins
- Group 2: Communication & Coping Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there a recruitment period for prospective participants in this research?
"According to clinicaltrials.gov, this medical trial is no longer open for recruitment. This study was first published on April 1st 2019 and last modified on September 6th 2022; thus, it has been discontinued but there are still 370 other trials actively seeking participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger